ORETON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oreton, and when can generic versions of Oreton launch?
Oreton is a drug marketed by Schering and is included in two NDAs.
The generic ingredient in ORETON is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oreton
A generic version of ORETON was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
Summary for ORETON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Patent Applications: | 4,351 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORETON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ORETON
US Patents and Regulatory Information for ORETON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | ORETON | methyltestosterone | TABLET;BUCCAL | 080281-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |